- Arizona’s Bioscience Roadmap
- Bioscience Grantmaking
Building Arizona as a global center for research and commercialization in the biosciences.
Connect with Flinn Bioscience: Stay up to date. Join our email list.
The Flinn Foundation supports the biosciences in Arizona through research grants and stewardship of Arizona’s Bioscience Roadmap, guiding the growth and development of the state’s bioscience sector through 2025.
The Roadmap’s tagline, “Advancing the Biosciences and Improving Health Outcomes” recognizes the broad spectrum of the biosciences, including research, academia, and product commercialization, as well as the central role of health care within the bioscience sector.
This year marks the 20th anniversary of both the Arizona’s Bioscience Roadmap and TGen, which through its cutting-edge patient treatment, ground-breaking research, and commercialization, has played a key role in enabling Arizona’s bioscience sector to perform today at historically high levels.
Dr. Jeffrey Trent, TGen’s president and research director and previously the scientific director of the National Human Genomic Research Institute, talks about his vision to create such an organization—and to do so in his native Arizona. [Read more]
A leading Northern Arizona University researcher and a Scottsdale pulmonologist who serves in HonorHealth leadership have been elected to the Flinn Foundation board of directors.
The election of Julie Baldwin, Ph.D., Regents Professor of health sciences and the founding director of NAU’s Center for Health Equity Research, and Dr. Alpa Shah, a physician who serves on the HonorHealth board of directors and as chief of staff at HonorHealth Scottsdale Osborn Medical Center, increases the number of Flinn Foundation board members to 10. [Read more]
Arizona’s bioscience sector is performing at historically high levels two decades after the creation of Arizona’s Bioscience Roadmap, according to the latest performance analysis by TEConomy Partners, with record highs in bioscience jobs, wages, venture capital, National Institutes of Health research funding, and university research and development.
The increases are striking: from 73,000 to 133,000 in bioscience jobs, including hospitals; $34 million to $240 million in venture capital; $133 million to $297 million in NIH funding; and $273 million to $623 in academic R&D. [Read more]
The first treatment for West Nile virus. A robotic device for children with cerebral palsy. A universal antivenom for snake bites.
These goals emerge from three of the translational research projects funded in 2022 by the Flinn Foundation’s program to advance new products and services to improve patient care. Each project will receive a $100,000 grant over the next 18 months. The 10 grants were awarded to Arizona State University, Northern Arizona University, Translational Genomics Research Institute, and University of Arizona, which are collaborating with other Arizona institutions. [Read more]
The University of Arizona College of Medicine-Phoenix will receive $5.5 million over five years from the Flinn Foundation to support translational research in cardiovascular diseases, neurosciences, and serious mental illnesses.
The grant, which will help advance research in these areas towards the clinical development of therapeutics, will establish new faculty positions and help develop the Translational Cardiovascular Research Center and a new Department of Translational Neurosciences. Funding will also create an intern program for underrepresented high school students. [Learn more] [Watch video]
CDC grants UArizona $22 million to continue studying COVID-19 / KGUN The Center for Disease Control is awarding the University of Arizona $22 million that will enable the Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance, or AZ HEROES, to conduct a third year of COVID-19 research. Biotech meets in person / Tech Nation […]
The Flinn Foundation in 2002 launched Arizona’s Bioscience Roadmap, which has guided the state’s growth in the biosciences over the past two decades. The Translational Genomics Research Institute, or TGen, began that same year in downtown Phoenix and quicky established itself as a leader in translational research and precision medicine—and an anchor of Arizona’s new […]
TGen launches MindCrowd 2.0 / Frontdoors MindCrowd, a unique online research project by the Translational Genomics Research Institute aimed at finding the factors that affect the brain’s functioning as we age, has added new tests and smartphone access in its next push toward its goal of one million participants. State leaders say Arizona will emerge as a […]
Deal count is down, but Arizona’s VC investment surges in second quarter / Phoenix Business Journal The latest quarterly Venture Monitor report revealed Arizona companies hauled in $463 million during the latest quarter, up from $201 million a year earlier and $228 million in the first quarter, even though the number of deals declined. Tucson […]